Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

2.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.7K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
The Thyroid Gland01:23

The Thyroid Gland

3.9K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

When hidden steroids cause harm: Secondary adrenal insufficiency from unrecognised exposure.

The Malaysian journal of pathology·2026
Same author

[Variables associated with severe cytopenia in adult chronic phase chronic myeloid leukemia patients receiving initial tyrosine kinase inhibitors].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

[Clinical efficacy of endoscopic transnasal orbital decompression combined with optic nerve decompression for Graves ophthalmopathy: a retrospective study].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2026
Same author

[Minutes of the 2025 ESR&ISIAN&IRS Conference in Budapest, Hungary].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

[Endoscopic transorbital approach to the orbital apex and skull base: an applied anatomical study].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

Diagnostic accuracy of high-sensitivity troponin I in an accelerated protocol to assess 30-day outcomes among chest pain patients in the emergency department.

The Malaysian journal of pathology·2025

Related Experiment Video

Updated: Jun 27, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.6K

Refractory hypothyroidism.

Y Y Lai1, S C Thambiah2, N Mohamed Mokhtar1

  • 1Hospital Kuala Lumpur, Department of Pathology, Ministry of Health Malaysia.

The Malaysian Journal of Pathology
|April 29, 2024
PubMed
Summary

The levothyroxine (LT4) absorption test can quickly and affordably rule out true malabsorption in patients with persistently high thyroid stimulating hormone (TSH) levels. This test helps avoid unnecessary specialist referrals and confirms appropriate LT4 dosing.

More Related Videos

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

828
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.6K

Related Experiment Videos

Last Updated: Jun 27, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.6K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

828
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.6K

Area of Science:

  • Endocrinology
  • Thyroidology
  • Pharmacokinetics

Background:

  • Persistent high thyroid stimulating hormone (TSH) despite supra-therapeutic levothyroxine (LT4) doses is a common clinical challenge.
  • This presentation often prompts investigations into LT4 malabsorption or non-adherence, which is difficult to ascertain.
  • Accurate patient accountability is crucial but challenging to confirm in cases of suspected non-adherence.

Observation:

  • A case report details a 35-year-old female with Graves' disease on LT4 therapy presenting with hypothyroidism despite reported adherence.
  • Initial lab work was within normal limits, leading to suspicion of pseudomalabsorption.
  • An LT4 absorption test revealed a significant increase in free thyroxine and appropriate TSH decrease within 4 hours, normalizing with directly observed LT4 administration.

Findings:

  • The LT4 absorption test demonstrated adequate LT4 absorption when administered under direct observation.
  • This suggests that the patient's initial presentation was due to pseudomalabsorption rather than true malabsorption or non-adherence.
  • The test validated the need for dose adjustment and confirmed the efficacy of observed LT4 intake.

Implications:

  • The LT4 absorption test provides a rapid and cost-effective method to differentiate true malabsorption from other causes of elevated TSH.
  • It can significantly reduce unnecessary referrals to subspecialists for malabsorption workups.
  • This diagnostic tool aids in validating and optimizing weight-adjusted LT4 dosage, improving patient management.